MX347325B - Bloqueadores del canal de calcio de fenilalquilamina de accion corta y sus usos. - Google Patents

Bloqueadores del canal de calcio de fenilalquilamina de accion corta y sus usos.

Info

Publication number
MX347325B
MX347325B MX2009014052A MX2009014052A MX347325B MX 347325 B MX347325 B MX 347325B MX 2009014052 A MX2009014052 A MX 2009014052A MX 2009014052 A MX2009014052 A MX 2009014052A MX 347325 B MX347325 B MX 347325B
Authority
MX
Mexico
Prior art keywords
calcium channel
channel blockers
short acting
methods
relates
Prior art date
Application number
MX2009014052A
Other languages
English (en)
Other versions
MX2009014052A (es
Inventor
P Maguire Martin
Rioux Elise
j leighton Harry
Original Assignee
Milestone Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Milestone Pharmaceuticals Inc filed Critical Milestone Pharmaceuticals Inc
Publication of MX2009014052A publication Critical patent/MX2009014052A/es
Publication of MX347325B publication Critical patent/MX347325B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C07C255/43—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms the carbon skeleton being further substituted by singly-bound oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refiere al el uso de una cantidad farmacéuticamente efectiva de un compuesto bloqueador de canal de calcio de corta acción para tratar condiciones isquémicas del corazón, arritmias cardiacas, crisis de hipertensión en un ambiente de sala de emergencias, hipertensión antes, durante y después de cirugía, fenómeno de no reflujo después de repercusión, y enfermedades asociadas con flujo sanguíneo muscular esquelético disminuido. La invención también se refiere a composiciones farmacéuticas formuladas para uso en tales métodos y a Kits para tales métodos.
MX2009014052A 2007-06-20 2008-06-19 Bloqueadores del canal de calcio de fenilalquilamina de accion corta y sus usos. MX347325B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93644007P 2007-06-20 2007-06-20
PCT/US2008/007665 WO2008156820A1 (en) 2007-06-20 2008-06-19 Short acting phenylalkylamine calcium channel blockers and uses thereof

Publications (2)

Publication Number Publication Date
MX2009014052A MX2009014052A (es) 2010-03-01
MX347325B true MX347325B (es) 2017-04-12

Family

ID=40156562

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009014052A MX347325B (es) 2007-06-20 2008-06-19 Bloqueadores del canal de calcio de fenilalquilamina de accion corta y sus usos.

Country Status (19)

Country Link
US (16) US20100190852A1 (es)
EP (1) EP2170050B1 (es)
JP (1) JP5421908B2 (es)
KR (1) KR101541557B1 (es)
CN (1) CN101754678B (es)
AU (1) AU2008266798B2 (es)
BR (1) BRPI0812919B8 (es)
CA (1) CA2693627C (es)
CY (1) CY1115619T1 (es)
DK (1) DK2170050T3 (es)
ES (1) ES2498047T3 (es)
HK (1) HK1140913A1 (es)
HR (1) HRP20140801T1 (es)
MX (1) MX347325B (es)
NZ (1) NZ582033A (es)
PL (1) PL2170050T3 (es)
PT (1) PT2170050E (es)
SI (1) SI2170050T1 (es)
WO (1) WO2008156820A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX347325B (es) 2007-06-20 2017-04-12 Milestone Pharmaceuticals Inc Bloqueadores del canal de calcio de fenilalquilamina de accion corta y sus usos.
KR101052620B1 (ko) * 2008-08-28 2011-07-29 한국과학기술연구원 신규 페닐아세테이트 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 ｔ-형 칼슘 이온 채널의 활성에 의해 유발되는 질환의 예방 또는 치료용 조성물
PL2482658T3 (pl) * 2009-09-30 2015-10-30 Microdose Therapeutx Inc Sposoby i kompozycje do leczenia objawu Raynauda
WO2015073919A1 (en) * 2013-11-14 2015-05-21 University Medical Pharmaceuticals Corporation Microneedles for therapeutic agent delivery with improved mechanical properties
ME03679B (me) * 2015-04-14 2020-10-20 Milestone Pharmaceuticals Inc Soli kratkodelujućeg fenilalkilamina, bloкatora кalcijumsкih кanala, које su visoko rastvorljive u vodi i njihova primena
EP4119137A1 (en) * 2021-07-15 2023-01-18 Milestone Pharmaceuticals Inc. Methods of administration for highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154810B (de) * 1961-04-01 1963-09-26 Knoll Ag Verfahren zur Herstellung basisch substituierter Phenylacetonitrile
US3957845A (en) * 1962-04-27 1976-05-18 Knoll A.G. Chemische Fabriken Trifluoromethyl-substituted phenyl acetonitriles
DE1493904A1 (de) * 1965-07-31 1969-06-19 Knoll Ag Verfahren zur Herstellung basisch substituierter Phenylacetonitrile
DE2059923C3 (de) * 1970-12-05 1979-01-25 Knoll Ag, 6700 Ludwigshafen l-a-Isopropyl-o-[(N-methyl-N-homoveratryl)v-aminopropyl] -3,4-dimethoxyphenylacetonitril, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel
JPS5118940B2 (es) * 1971-12-25 1976-06-14
DE2631222C3 (de) * 1976-07-12 1979-01-04 Knoll Ag, 6700 Ludwigshafen Verfahren zur Herstellung basisch substituierter Phenylacetonitrile
DE3144150A1 (de) * 1981-04-10 1982-12-09 Basf Ag, 6700 Ludwigshafen (omega)-cyan-1,(omega)-diphenyl-azaalkan-derivate, ihre herstellung und diese enthaltende arzneimittel
DE3433383A1 (de) * 1984-09-12 1986-03-20 Boehringer Mannheim Gmbh, 6800 Mannheim Neue phenyl-acetonitril-derivate
DE3603032A1 (de) * 1986-01-31 1987-08-06 Basf Ag Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel
US4833162A (en) * 1988-02-03 1989-05-23 American Cyanamid Company Substituted benzeneacetonitriles and their use as calcium channel blockers
US5486539A (en) * 1989-12-21 1996-01-23 G. D. Searle & Co. Method of using phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives
IE64870B1 (en) 1989-12-21 1995-09-20 Searle & Co Methods of using 2-isopropyl-2-phenylaminovaleronitriles immunosuppressants and vasodilators
US5162569A (en) 1989-12-21 1992-11-10 G. D. Searle & Co. Phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives
US5247119A (en) * 1990-12-12 1993-09-21 G. D. Searle & Co. Phenylacetonitrilehydroxyalkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives
US6057344A (en) * 1991-11-26 2000-05-02 Sepracor, Inc. Methods for treating hypertension, and angina using optically pure (-) amlodipine
US5451604A (en) * 1993-07-26 1995-09-19 G. D. Searle & Co. Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressives
US5910601A (en) * 1994-09-26 1999-06-08 Darwin Discovery Limited Chiral nitriles, their preparation and their use for the manufacture of verapamil and analogues
US5859279A (en) 1996-09-10 1999-01-12 Darwin Discovery Limited Compound and process
US6750238B1 (en) 2000-05-12 2004-06-15 The University Of Toledo Aralkyl ester soft drugs
US7511077B2 (en) * 2005-02-09 2009-03-31 Neuromed Pharmaceuticals Ltd. Diamine calcium channel blockers
GB2435824A (en) 2006-03-09 2007-09-12 Esteve Labor Dr Use of nitrile compounds in the treatment of food related and other disorders
MX347325B (es) 2007-06-20 2017-04-12 Milestone Pharmaceuticals Inc Bloqueadores del canal de calcio de fenilalquilamina de accion corta y sus usos.

Also Published As

Publication number Publication date
EP2170050B1 (en) 2014-06-18
CA2693627A1 (en) 2008-12-24
US20140296335A1 (en) 2014-10-02
HRP20140801T1 (hr) 2014-11-21
PL2170050T3 (pl) 2014-12-31
AU2008266798B2 (en) 2014-07-17
US20210059972A1 (en) 2021-03-04
US20170312242A1 (en) 2017-11-02
CY1115619T1 (el) 2017-01-04
KR101541557B1 (ko) 2015-08-03
BRPI0812919A2 (pt) 2014-10-07
EP2170050A4 (en) 2010-11-24
US20180280339A1 (en) 2018-10-04
CN101754678B (zh) 2014-04-16
DK2170050T3 (da) 2014-09-29
CN101754678A (zh) 2010-06-23
MX2009014052A (es) 2010-03-01
WO2008156820A1 (en) 2008-12-24
JP5421908B2 (ja) 2014-02-19
US9463179B2 (en) 2016-10-11
KR20100043175A (ko) 2010-04-28
US20240115543A1 (en) 2024-04-11
HK1140913A1 (en) 2010-10-29
BRPI0812919B8 (pt) 2021-05-25
ES2498047T3 (es) 2014-09-24
US20160374982A1 (en) 2016-12-29
US20220142963A1 (en) 2022-05-12
US20190380993A1 (en) 2019-12-19
US20210315855A1 (en) 2021-10-14
AU2008266798A1 (en) 2008-12-24
US20200230097A1 (en) 2020-07-23
US9737503B2 (en) 2017-08-22
CA2693627C (en) 2016-01-12
SI2170050T1 (sl) 2014-12-31
JP2010530429A (ja) 2010-09-09
US20100190852A1 (en) 2010-07-29
US20170312241A1 (en) 2017-11-02
US20190142781A1 (en) 2019-05-16
US10010522B2 (en) 2018-07-03
US20160074354A1 (en) 2016-03-17
US9227918B2 (en) 2016-01-05
US10010523B2 (en) 2018-07-03
NZ582033A (en) 2012-07-27
US20230255923A1 (en) 2023-08-17
US10010524B2 (en) 2018-07-03
EP2170050A1 (en) 2010-04-07
US20170312243A1 (en) 2017-11-02
BRPI0812919B1 (pt) 2019-01-29
PT2170050E (pt) 2014-09-04

Similar Documents

Publication Publication Date Title
MX2009014052A (es) Bloqueadores del canal de calcio de fenilalquilamina de accion corta y sus usos.
HRP20160646T1 (hr) Poboljšano liječenje multiplog mijeloma
ECSP077296A (es) Fenilaminotiazoles sustituidos y su uso
BRPI0412314B8 (pt) composto 3-[2(r)-{hidroxicarbonilpropil-amino}-2-feniletil]-5-(2-flúor-3-metoxifenil)-1-[2-flúor-6-(trifluorometil)benzil]-6-metil-pirimidina-2,4(1h,3h)-diona, composição farmacêutica compreendendo dito composto e uso do mesmo para o tratamento de uma condição relacionada ao hormônio sexual
EA201071038A1 (ru) Производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40
BR112012018386A8 (pt) "inibidores isoindolinona de fosfatidilinositol 3-quinase"
MX2009008253A (es) Derivados de 2-aminopiridina utiles como inhibidores de cinasa.
NO20063693L (no) Forbindelse og metode for anvendelse
EP2422819A3 (en) Compositions and their uses directed to Huntingtin
NO20100301L (no) Forbedrete brimonidinsammensetninger for behandling av erytem
NO20076319L (no) Farmasoytiske sammensetninger av et neuroaktivt steroid og anvendelse derav
WO2009109616A3 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxrl and p40
WO2010011772A3 (en) Tri-cyclic pyrazolopyridine kinase inhibitors
MX2009006345A (es) Compuestos utiles como inhibidores de proteina cinasa.
WO2007109251A3 (en) Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases
CL2007002689A1 (es) Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
EA200971107A1 (ru) Катехоламиновые производные, полезные для лечения болезни паркинсона
RU2009120990A (ru) Применение тестостерона и агониста 5-нт1а для лечения сексуальной дисфункции
BRPI0511979A (pt) derivados de triazóis substituìdos como antagonistas de oxitocina, composição farmacêutica compreendendo os referidos derivados, bem como uso dos mesmos
MX2011013648A (es) Nuevos compuestos, composiciones farmaceuticas y metodos relacionados con ellos.
WO2009109654A8 (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1
IL205696A0 (en) Heterocyclic derivatives, compositions comprising the same and uses thereof
WO2010121675A3 (en) Thiazolyl-benzimidazoles
MX2021013942A (es) Metodos de tratamiento de la urticaria cronica espontanea utilizando un inhibidor de la tirosina quinasa de bruton.
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration